I'll have a go at arguing the positives. Agree there are obvious conflicts with software development , property rental and a management fee paid to entities associated with the 72 percent major shareholder and executive chairman ( doesn't read too good ok). These conflicts are however clearly disclosed and the Board looks reasonable.
Medtech Global as a software company is however more leveraged to success than some of these other companies associated with the Chairman i.e. In a a two horse race back the one called vested interest.
The Chair has been buying shares over the last few years .
Additionally manage my heath website appears to be the leading consumer portal in NZ now . The circa 50 percent owned Heath insurance verification business Consova in the US looks to be getting traction on the back of Obama Heath insurance changes .
So in summary Medtech has always had conflicts but the underlying business feels like it's improving. Maybe play the ball not the man?
- Forums
- ASX - By Stock
- MDG
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly , page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online